APGE: Apogee Therapeutics, Inc. Stock

by  •  • Comments Off on APGE: Apogee Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,844.47
Enterprise Value ($M) 2,359.01
Book Value ($M) 801.48
Book Value / Share 13.71
Price / Book 3.55
NCAV ($M) 798.43
NCAV / Share 13.66
Price / NCAV 3.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 38.08
Current Ratio 38.08

Balance Sheet (mrq) ($M)
Current Assets 820.61
Assets 823.66
Liabilities 22.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -93.00
Net Income -83.98

Cash Flow Statement (mra) ($M)
Cash From Operations -74.76
Cash from Investing -273.91
Cash from Financing 315.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13D/A Fairmount Funds Management LLC 9.99 -11.85
02-14 13G/A Deep Track Capital, LP 6.25 -23.15
02-14 13G Ra Capital Management, L.p. 5.30
02-09 13G/A Fmr Llc 13.50 12.84
11-03 13G Access Industries Management, Llc 5.22
07-28 13D Venrock Healthcare Capital Partners III, L.P. 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark one)
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 57,122 289,324 19.74
2024-07-25 44,784 287,387 15.58
2024-07-24 69,441 276,383 25.12
2024-07-23 52,263 220,772 23.67
2024-07-22 51,757 311,545 16.61

(click for more detail)

Similar Companies
ALIM – Alimera Sciences, Inc. ALT – Altimmune, Inc.
ANIP – ANI Pharmaceuticals, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io